| Q59127644 | A Novel Glycoproteomics Workflow Reveals Dynamic O-GlcNAcylation of COPγ1 as a Candidate Regulator of Protein Trafficking |
| Q55226110 | A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen. |
| Q37469879 | A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer. |
| Q42425049 | A mutant O-GlcNAcase as a probe to reveal global dynamics of protein O-GlcNAcylation during Drosophila embryonic development |
| Q34410704 | A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome. |
| Q44279217 | A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase |
| Q49846411 | Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27-28, 2017, Tours, France |
| Q36536065 | Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI. |
| Q34359019 | Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code |
| Q34961829 | Biochemical characterization and membrane topology of Alg2 from Saccharomyces cerevisiae as a bifunctional alpha1,3- and 1,6-mannosyltransferase involved in lipid-linked oligosaccharide biosynthesis |
| Q36298206 | Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle |
| Q39037656 | Chemical Glycoproteomics |
| Q35648339 | Chemical approaches to understanding O-GlcNAc glycosylation in the brain |
| Q27687493 | Chemical arsenal for the study of O-GlcNAc. |
| Q42556439 | Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging |
| Q33264134 | Chemoenzymatic synthesis of glycan libraries. |
| Q37540109 | Click Chemistry and Radiochemistry: The First 10 Years |
| Q44509252 | Comparison of the closed conformation of the beta 1,4-galactosyltransferase-1 (beta 4Gal-T1) in the presence and absence of alpha-lactalbumin (LA). |
| Q36998516 | Comprehensive mapping of O-GlcNAc modification sites using a chemically cleavable tag |
| Q58564337 | Critical observations that shaped our understanding of the function(s) of Intracellular Glycosylation (O-GlcNAc) |
| Q28829290 | Current Status: Site-Specific Antibody Drug Conjugates |
| Q59727965 | Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics |
| Q41189292 | Detecting O-GlcNAc using in vitro sulfation |
| Q38272067 | Detection and identification of O-GlcNAcylated proteins by proteomic approaches. |
| Q30830469 | Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method |
| Q37151037 | Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units. |
| Q92366099 | Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs |
| Q42105089 | Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry |
| Q37491643 | Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase. |
| Q24561943 | Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain |
| Q45162691 | Functional analysis of Drosophila beta1,4-N-acetlygalactosaminyltransferases |
| Q42180523 | Genetic Interactions Between Drosophila sialyltransferase and β1,4-N-acetylgalactosaminyltransferase-A Genes Indicate Their Involvement in the Same Pathway |
| Q91152191 | Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation |
| Q35122790 | Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneumococcal strain producing three different capsular repeat units |
| Q35093056 | Glucosaminylglycan biosynthesis: what we can learn from the X-ray crystal structures of glycosyltransferases GlcAT1 and EXTL2. |
| Q38178370 | Glycosylation of the nuclear pore |
| Q38728088 | Glycosyltransferase engineering for carbohydrate synthesis |
| Q42757288 | Highly efficient chemoenzymatic synthesis of beta1-4-linked galactosides with promiscuous bacterial beta1-4-galactosyltransferases |
| Q92469912 | Identifying potentially O-GlcNAcylated proteins using metabolic labeling, bioorthogonal enrichment, and Western blotting |
| Q49549460 | Imaging specific cellular glycan structures using glycosyltransferases via click chemistry. |
| Q34703755 | Improved synthesis of UDP-2-(2-ketopropyl)galactose and a first synthesis of UDP-2-(2-ketopropyl)glucose for the site-specific linking of biomolecules via modified glycan residues using glycosyltransferases |
| Q47227536 | Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation |
| Q90616209 | Molecular Interrogation to Crack the Case of O-GlcNAc |
| Q24321810 | Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N'-diacetyllactosediamine, galNAc beta 1-4GlcNAc |
| Q42682066 | Molecular cloning and enzymatic characterization of a UDP-GalNAc:GlcNAc(beta)-R beta1,4-N-acetylgalactosaminyltransferase from Caenorhabditis elegans |
| Q36108943 | Multiple site-specific in vitro labeling of single-chain antibody |
| Q36439174 | Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI |
| Q36407336 | Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase. |
| Q38193224 | O-GlcNAc profiling: from proteins to proteomes |
| Q34498193 | O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension |
| Q90736495 | On enzymatic remodeling of IgG glycosylation; unique tools with broad applications |
| Q57287553 | Optimization of Chemoenzymatic Mass Tagging by Strain-Promoted Cycloaddition (SPAAC) for the Determination of O-GlcNAc Stoichiometry by Western Blotting |
| Q24297510 | Phosphofructokinase 1 glycosylation regulates cell growth and metabolism |
| Q100954223 | Photoactivatable Fluorophore for STED Microscopy and Bioconjugation Technique for Hydrophobic Labels |
| Q37403530 | Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate |
| Q35011428 | Protein gel staining methods: an introduction and overview |
| Q34075637 | Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags |
| Q42798614 | Quantitative time-resolved chemoproteomics reveals that stable O-GlcNAc regulates box C/D snoRNP biogenesis |
| Q50325365 | Rapid screening of sugar-nucleotide donor specificities of putative glycosyltransferases. |
| Q51353442 | Recombinant fungal lectin as a new tool to investigate O-GlcNAcylation processes. |
| Q35033333 | Remarkable structural similarities between diverse glycosyltransferases |
| Q35018981 | Reversible hydrazide chemistry-based enrichment for O-GlcNAc-modified peptides and glycopeptides having non-reducing GlcNAc residues |
| Q35748282 | Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates |
| Q33441587 | Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection |
| Q55022669 | Site-Specific Antibody Conjugation for ADC and Beyond. |
| Q28078378 | Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans |
| Q37066864 | Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes |
| Q37593705 | Site-specific antibody drug conjugates for cancer therapy |
| Q35105725 | Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development |
| Q35526950 | Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar |
| Q37736782 | Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation |
| Q36732080 | Site-specific linking of biomolecules via glycan residues using glycosyltransferases |
| Q26780335 | Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics |
| Q37048457 | Streptococcus pneumoniae serotype 11D has a bispecific glycosyltransferase and expresses two different capsular polysaccharide repeating units |
| Q27660380 | Structural Analysis of Thermus thermophilus HB27 Mannosyl-3-phosphoglycerate Synthase Provides Evidence for a Second Catalytic Metal Ion and New Insight into the Retaining Mechanism of Glycosyltransferases |
| Q27643682 | Structural effects of naturally occurring human blood group B galactosyltransferase mutations adjacent to the DXD motif |
| Q36627413 | Structure and function of beta -1,4-galactosyltransferase |
| Q30392577 | Structure-based evolutionary relationship of glycosyltransferases: a case study of vertebrate β1,4-galactosyltransferase, invertebrate β1,4-N-acetylgalactosaminyltransferase and α-polypeptidyl-N-acetylgalactosaminyltransferase |
| Q46140725 | Synthesis of LacdiNAc-terminated glycoconjugates by mutant galactosyltransferase--a way to new glycodrugs and materials |
| Q90833282 | Targeted delivery of nitric oxide via a 'bump-and-hole'-based enzyme-prodrug pair |
| Q40431483 | The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System |
| Q35703104 | The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2. |
| Q38533861 | The Utilities of Chemical Reactions and Molecular Tools for O-GlcNAc Proteomic Studies |
| Q37152815 | The chemical neurobiology of carbohydrates |
| Q36790068 | Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors |
| Q36540585 | Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface |
| Q37596815 | Visualization of O-GlcNAc glycosylation stoichiometry and dynamics using resolvable poly(ethylene glycol) mass tags |